Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Lilly’s Olomorasib Gains FDA Breakthrough Therapy Status
Eli Lilly and Company has secured Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for olomorasib, an investigational medicine being developed for adults with advanced pancreatic cancer carrying a KRAS G12C mutation....
Takeda Secures FDA Approval for ORZEYFUL in Narcolepsy Type 1
Takeda has secured US Food and Drug Administration (FDA) approval for ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist for treating narcolepsy type 1 (NT1) in adults....
Allogene’s Cema-cel Gains FDA Fast Track and RMAT Designations for LBCL Treatment
Allogene Therapeutics has announced that its investigational allogeneic CAR T-cell therapy, cemacabtagene ansegedleucel (cema-cel), has received Regenerative Medicine Advanced...
University of Queensland Researchers Unlock New Drug Target for Neurodegenerative Disease Therapies
University of Queensland (UQ) researchers have developed a novel drug molecule that targets the hard-to-study immune receptor C5aR2, opening new possibilities for treatments targeting neurodegenerative diseases such as Motor Neurone Disease (MND)....
Merck Secures FDA Approval for First Oral PCSK9 Inhibitor LIPFENDRA to Treat High LDL Cholesterol
Merck has received approval from the US Food and Drug Administration (FDA) for LIPFENDRA® (enlicitide) 20 mg, making it the first oral PCSK9 inhibitor authorised in the United States....
Orca Bio Gains FDA Approval for TREGZI to Improve Stem Cell Transplant Outcomes
Orca Bio has received approval from the U.S. Food and Drug Administration (FDA) for TREGZI™ (allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq), a precision-engineered...
Kowa’s K-808 Receives FDA Breakthrough Therapy Designation for Primary Biliary Cholangitis
Kowa Company has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to its investigational therapy, K-808 (pemafibrate), for the treatment of primary biliary cholangitis (PBC)....
Ionis Pharmaceuticals Receives FDA Approval for TRYNGOLZA to Treat Severe Hypertriglyceridaemia
Ionis Pharmaceuticals has received US Food and Drug Administration (FDA) approval for TRYNGOLZA® (olezarsen) as an adjunct to diet for adults with severe hypertriglyceridaemia (sHTG), defined as triglyceride levels of 500 mg/dL or higher....
FDA Grants Breakthrough Therapy Designation to Calico's Fosigotifator
Calico Life Sciences LLC has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to fosigotifator for the treatment of Vanishing White Matter disease, a rare and progressive neurological disorder with no approved therapies....
UniXell secures US FDA clearance for Parkinson's disease cell therapy
UniXell Biotechnology has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) for UX-DA003, its allogeneic induced pluripotent stem cell (iPSC)-derived therapy for Parkinson's disease. The approval follows the candidate's earlier IND clearance from China...
